Franklin Resources’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.3M	Sell	305,211 -162,967	-35%	-$6.09M	﹤0.01%	1162
2025 Q4	$16.3M	Sell	468,178 -31,879	-6%	-$2.5M	﹤0.01%	1018
2025 Q3	$41.6M	Buy	500,057 +10,717	+2%	+$776K	0.01%	703
2025 Q2	$35.9M	Buy	489,340 +156,248	+47%	+$11.3M	0.01%	734
2025 Q1	$38M	Buy	333,092 +59,118	+22%	+$3.6M	0.01%	696
2024 Q4	$13.8M	Buy	273,974 +31,183	+13%	+$1.63M	﹤0.01%	1015
2024 Q3	$11M	Buy	242,791 +2,475	+1%	+$87.9K	﹤0.01%	1088
2024 Q2	$7.81M	Sell	240,316 -5,146	-2%	-$141K	﹤0.01%	1158
2024 Q1	$6.18M	Buy	245,462 +17,877	+8%	+$422K	﹤0.01%	1249
2023 Q4	$7.39M	Buy	227,585 +4,471	+2%	+$123K	﹤0.01%	1015
2023 Q3	$6.08M	Sell	223,114 -20,704	-8%	-$599K	﹤0.01%	1033
2023 Q2	$5.42M	Buy	243,818 +20,647	+9%	+$475K	﹤0.01%	1089
2023 Q1	$4.83M	Sell	223,171 -15,944	-7%	-$350K	﹤0.01%	1098
2022 Q4	$4.86M	Sell	239,115 -15,226	-6%	-$382K	﹤0.01%	1116
2022 Q3	$6.52M	Buy	254,341 +46	+0%	+$1.23K	﹤0.01%	1034
2022 Q2	$6.05M	Buy	+254,295	New	+$5.54M	﹤0.01%	1066